Qualifying conditions
Every condition that qualifies a Kentucky resident for medical cannabis registration under KRS Chapter 218B, with plain-language guidance on how cannabis fits — cannabinoids, terpenes, formats, and the questions worth asking. Educational only. Your practitioner remains your first call.
Chronic Pain
Chronic pain is the most common reason patients pursue medical cannabis registration in Kentucky. If your pain has outlasted the injury or condition that caused it, or if standard treatments are giving diminishing returns without giving your life back, cannabis is worth a conversation with your practitioner.
Post-Traumatic Stress Disorder
PTSD affects veterans, first responders, survivors of assault, and anyone who's lived through trauma the body won't stop replaying. Kentucky lists PTSD as a qualifying condition under KRS 218B. If nightmares, hypervigilance, or dissociation are wearing down your daily life, this page is a starting point — not a substitute for a practitioner conversation.
Cancer
Cancer is a qualifying condition under KRS 218B — not because cannabis treats the cancer, but because it helps patients live through treatment. Chemotherapy nausea, appetite collapse, sleep loss, and cancer pain are the four common reasons oncology patients register. Your oncologist and your practitioner should both know you're using cannabis.
Epilepsy & Seizure Disorders
Kentucky includes intractable seizure disorders among qualifying conditions under KRS 218B. Epilepsy is the condition with the strongest published evidence for cannabis therapy — CBD is the star, and one CBD-based drug (Epidiolex) is FDA-approved for specific epilepsy syndromes. This page is educational; a neurologist has to be part of any epilepsy plan.
Multiple Sclerosis & Muscle Spasticity
Multiple sclerosis and muscle spasticity from other neurological conditions are qualifying conditions under KRS 218B. Spasticity is the involuntary muscle tightening that comes with MS, spinal cord injury, and cerebral palsy. Cannabis has a longer research track record here than for most conditions — including a European-approved pharmaceutical (Sativex) built from cannabis extracts specifically for MS spasticity.
Chronic Nausea
Chronic or severe nausea is a qualifying condition under KRS 218B — whether from chemotherapy, gastroparesis, chronic pancreatitis, or a nausea disorder without a clear cause. Cannabis has decades of evidence behind it for this symptom, and it's often what lets patients eat, keep medication down, and hold weight.
Terminal Illness & Hospice
Terminal illness with a life expectancy of one year or less is a qualifying condition under KRS 218B. At this stage, the goal isn't cure — it's comfort, presence, and quality of the time that's left. Cannabis is one of the tools hospice teams increasingly welcome. This page is for patients, families, and caregivers.
Sickle Cell Anemia
Sickle cell anemia is a qualifying condition under KRS 218B. Sickle cell pain — both crisis pain and the chronic background pain between crises — is one of the most under-treated pain conditions in American medicine. Cannabis is increasingly part of the conversation, especially as opioid prescribing tightens for chronic sickle cell patients.